two new biotech drugs for colorectal cancer
March 2004
You'll see two new biotech drugs for colorectal cancer, Avastin and Erbitux.
Avastin (bevacizumab) is the first angiogenesis inhibitor approved by the FDA. It works by slowing the growth of new blood vessels that tumors need to grow.
It's approved for metastatic colorectal cancer...in combination with traditional chemotherapy.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote